Southeast Asia and India remain challenging markets for private equity as they are still developing and have limited availability of vintage funds, senior executives at Switzerland-based Pictet Alternatives Advisors told DealStreetAsia. However, a growing cohort of specialised healthcare players in the region are nearing their third or fourth fund vintage, signalling gradual progress, they added.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
